CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 23 filers reported holding CELLECTAR BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,000 | -77.8% | 5,254 | -61.8% | 0.00% | – |
Q1 2022 | $9,000 | 0.0% | 13,754 | 0.0% | 0.00% | – |
Q4 2021 | $9,000 | -35.7% | 13,754 | -6.8% | 0.00% | -100.0% |
Q3 2021 | $14,000 | -17.6% | 14,754 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $17,000 | -29.2% | 14,754 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $24,000 | +2300.0% | 14,754 | +1375.4% | 0.00% | – |
Q3 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PVG ASSET MANAGEMENT CORP | 193,510 | $230,276,000 | 0.72% |
Consonance Capital Management LP | 3,913,000 | $4,656,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 217,500 | $259,000 | 0.13% |
FNY Investment Advisers, LLC | 220,321 | $262,000 | 0.10% |
SABBY MANAGEMENT, LLC | 426,561 | $508,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 297,653 | $354,000 | 0.04% |
Boxer Capital, LLC | 920,000 | $1,095,000 | 0.04% |
Maven Securities LTD | 650,000 | $793,000 | 0.03% |
Sterneck Capital Management, LLC | 30,000 | $34,000 | 0.02% |
1900 WEALTH MANAGEMENT LLC | 60,000 | $71,000 | 0.01% |